CAS 862507-23-1

Fórmula: C26H37FN6O6S2

InChI: InChI=1S/C24H29FN6.2CH4O3S/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6;2*1-5(2,3)4/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30);2*1H3,(H,2,3,4)

Clave InChI: NARMJPIBAXVUIE-UHFFFAOYSA-N

SMILES: CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O

LY2228820

CAS: 862507-23-1

Fórmula: C₂₆H₃₇FN₆O₆S₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 612.7370

Ref: IN-DA00GU43

LY2228820

CAS: 862507-23-1

LY2228820

Fórmula: C₂₄H₂₉FN₆·2CH₃SO₃H

Forma y color: Solid-Powder

Peso molecular: 612.73698

Ref: 54-BISN0222

Ralimetinib dimesylate

CAS: 862507-23-1

Ralimetinib dimesylate

Fórmula: C₂₄H₂₉FN₆·2CH₄O₃S

Pureza: ≥98%

Peso molecular: 612.74

Ref: 54-BUP04719

Ralimetinib dimesylate

CAS: 862507-23-1

5-(2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate

Fórmula: C₂₆H₃₇FN₆O₆S₂

Pureza: 98%

Peso molecular: 612.74

Ref: IN-DG306011

Ralimetinib dimesylate

CAS: 862507-23-1

Ralimetinib dimesylate (LY2228820 dimesylate) is a orally available, p38 MAPK inhibitor with potential anti-inflammatory and antineoplastic activities.

Fórmula: C₂₄H₂₉FN₆·2CH₄O₃S

Pureza: 98% - 99.82%

Forma y color: White Solid

Peso molecular: 612.74

Ref: TM-T6047

LY 2228820

Producto controlado

CAS: 862507-23-1

Fórmula: C₂₄H₂₉FN₆

Forma y color: Neat

Peso molecular: 420.526

Ref: TR-L486500

LY 2228820 dimesylate

CAS: 862507-23-1

Inhibitor of p38 mitogen-activated protein kinase

Fórmula: C₂₆H₃₇FN₆O₆S₂

Pureza: Min. 95%

Peso molecular: 612.74 g/mol

Ref: 3D-FL24961